drugset / Trial / NCT02114645
The Effect of GnRH Agonist Administered in the Luteal Phase on ART Cycle Outcomes
Non-randomizedCrossoverSingle-blindTreatment
Summary
This prospective clinical trial evaluates the effect of a two dose GnRH agonist administered in the luteal phase on the outcome of ART cycles stimulated with the long GnRH agonist and GnRH antagonist protocol.
Timeline
- Start
- 2014-04
- Primary completion
- 2015-02
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Leuprolide | Other / unclassified | 0.5 mg | Subcutaneous |
| Background | Progesterone | Other / unclassified | — | Intravenous |
| Background | estradiol valerate | Unknown | 4 mg | Oral |